Veterinary Vaccine Adjuvants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Veterinary Vaccine Adjuvants Market is segmented by Type, Route of Administration, Animal Type (Livestock, and Companion Animals), and Geography.

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The veterinary vaccine adjuvant market is anticipated to register a CAGR of around 6.4%, during the forecast period. The growth of this market is owing to several factors, such as the rising use of adjuvants in the vaccine, increasing livestock population and their associated diseases, and the high incidence of infectious zoonotic diseases. As per the Centers for Disease Control and Prevention (CDC), zoonotic diseases are very common and about three out of every four new or emerging infectious diseases in people are spread from animals, and more than six out of every 10 known infectious diseases in people are spread from animals. So, for the treatment of the aforementioned infectious zoonotic diseases, various types of vaccines are used. Thus, the growing burden of zoonotic diseases is among the major growth factor for the veterinary vaccine adjuvant market.

Scope of the Report

Vaccine adjuvants are substances that help to enhance the immune response of the vaccine. The adjuvants can be broadly classified into two types, the first one is vaccine delivery systems and the second one is immunostimulatory adjuvants.

By Type
Alum and Calcium Salts
Oil Emulsion Adjuvants
Liposomes and Archaeosomes
Nanoparticles and Microparticles
Other Types
By Route of Administration
Oral
Subcutaneous
Intramuscular
Other Routes of Administration
By Animal Type
Livestock
Companion Animal
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Alum and Calcium Salts Segment is Expected to Hold the Largest Share in the Market

Aluminum-based adjuvants have been used most commonly for vaccine preparations for more than 80 years. They include aluminum hydroxide and phosphate adjuvants, as well as calcium phosphate adjuvants. In addition, the safety of these adjuvants is excellent, and there are very few side effects. However, there are some allergic reactions and granulomas occasionally in a few cases. Moreover, recent developments, such as the use of aluminum oxyhydroxide nanoparticles in the formulation of vaccine adjuvants, are more effective in the prevention of infectious diseases and the treatment of various diseases. Furthermore, the increasing funding and investments for developing and producing new vaccines are boosting the segment.

Funding for Health Care Services(Millions), Global, 2017-2019

North America is Expected to Exhibit Major Contribution Over the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the rising adoption of companion animals, increasing pet healthcare insurance, and improved veterinary healthcare infrastructure. In the North American region, the United States holds the largest market share. Additionally, with the rising trends of zoonotic diseases in the United States, the associated use of veterinary vaccines is also increasing. Hence, it is expected to propel the growth of the veterinary vaccine adjuvants market over the forecast period.

Veterinary Vaccine Adjuvants Market - Growth Rate by Region

Competitive Landscape

The veterinary vaccine adjuvant market is moderately competitive and consists of several major players. In terms of market share, some of the major players currently dominate the market. With the rising prevalence of infectious diseases in the animals, few other smaller players are expected to enter the market in the coming years. Some of the major players of the market are SEPPIC, SPI Pharma, Brenntag Biosector AS, Bioveta AS, and Zoetis, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Use of Adjuvants in Vaccine

      2. 4.2.2 Increase in Livestock Population and their Associated Diseases

      3. 4.2.3 High Incidence of Infectious Zoonotic Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Toxicity and Side Effects of Adjuvants

      2. 4.3.2 Stringent Regulatory Environment and Time-consuming Approvals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Alum and Calcium Salts

      2. 5.1.2 Oil Emulsion Adjuvants

      3. 5.1.3 Liposomes and Archaeosomes

      4. 5.1.4 Nanoparticles and Microparticles

      5. 5.1.5 Other Types

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Subcutaneous

      3. 5.2.3 Intramuscular

      4. 5.2.4 Other Routes of Administration

    3. 5.3 By Animal Type

      1. 5.3.1 Livestock

      2. 5.3.2 Companion Animal

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bioveta AS

      2. 6.1.2 Brenntag Biosector AS

      3. 6.1.3 Novavax

      4. 6.1.4 Phibro Animal Health Corporation

      5. 6.1.5 SEPPIC

      6. 6.1.6 SPI Pharma

      7. 6.1.7 Zoetis

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Veterinary Vaccine Adjuvants Market market is studied from 2018 - 2026.

The Veterinary Vaccine Adjuvants Market is growing at a CAGR of 6.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

SEPPIC, SPI Pharma, Brenntag Biosector AS, Bioveta AS, Novavax are the major companies operating in Veterinary Vaccine Adjuvants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!